![Eric Rowinsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Rowinsky
Président chez
PURPLE BIOTECH LTD
Fortune : 5 M $ au 31/05/2026
Profil
Eric K.
Rowinsky founded Primrose Therapeutics, Inc. in 2010, where he worked as Chief Executive Officer from 2010 to 2011.
Dr. Rowinsky also currently works at Purple Biotech Ltd., as Chairman from 2019, Biogen, Inc., as Independent Director from 2011, Biogen Idec, Inc. (North Carolina), as Director, and various other companies.
Dr. Rowinsky also formerly worked at Navidea Biopharmaceuticals, Inc., as Chairman from 2016 to 2018, IDD, Inc., as Chairman-Early Drug Development from 1996 to 2004, Fortress Biotech, Inc., as Vice Chairman from 2010 to 2024, and various other companies.
Dr. Rowinsky received his undergraduate degree in 1977 from New York University and doctorate degree in 1981 from Vanderbilt University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOGEN INC. 0,02 % | 09/06/2026 | 25 844 ( 0,02 % ) | 5 M $ | 31/05/2026 |
VERASTEM, INC. 0,09 % | 21/05/2026 | 52 666 ( 0,09 % ) | 228 044 $ | 31/05/2026 |
Postes actifs de Eric Rowinsky
| Sociétés | Poste | Début |
|---|---|---|
| BIOGEN INC. | Directeur/Membre du Conseil | 23/03/2010 |
| PURPLE BIOTECH LTD | Président | 02/10/2019 |
| EVEREST MEDICINES LIMITED | Corporate Officer/Principal | 01/01/2017 |
| VERASTEM, INC. | Directeur/Membre du Conseil | 03/05/2017 |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Directeur/Membre du Conseil | 01/01/2010 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cancer | Directeur/Membre du Conseil | 01/09/2021 |
Oncotartis, Inc.
 Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01/01/2018 |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Directeur/Membre du Conseil | 05/01/2017 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Eric Rowinsky
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Eric Rowinsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
36
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 36 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Navidea Biopharmaceuticals, Inc.
 Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Cancer Therapy & Research Center Endowment
 Cancer Therapy & Research Center Endowment Medical/Nursing ServicesHealth Services Provides therapeutic and cancer research services | Health Services |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Fortress Biotech, Inc.
 Fortress Biotech, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and biotechnology products | Health Technology |
Primrose Therapeutics, Inc. | |
ImmuneXcite, Inc.
 ImmuneXcite, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which develops monoclonal antibodies for cancer | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Champions Oncology, Inc.
 Champions Oncology, Inc. BiotechnologyHealth Technology Provides advanced technology solutions and services for oncology drugs | Health Technology |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Texas University of Health Center at San Antonio
 Texas University of Health Center at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biophytis SA
 Biophytis SA Pharmaceuticals: OtherHealth Technology Develops and markets dietary supplements and ingredients for functional food based on tropical plants | Health Technology |
Maxwell Asset Management LLC (US)
 Maxwell Asset Management LLC (US) Investment ManagersFinance Maxwell Asset Management manages the Maxwell Biotech Venture Fund. The fund focuses on investments in the biotechnology and pharmaceutical sectors with emphasis on therapeutics, industrial biotechnology and agricultural/veterinary applications. Within the therapeutics industry, the Fund focuses on investments in clinical areas of oncology, diseases of the central nervous system and metabolic disorders. The Fund invests in the application of biotechnology for industrial purposes including the production of biofuels and industrial reagents. In addition, the Fund invests in the application of biotechnology to strategically important agricultural products, such as plant growth promoters, crop protectors and animal health products. The Fund invests in public and private companies in North America, Europe and other parts of the world. Maxwell looks for companies: (1) that are developing products and technologies that are synergistic with the Fund's existing portfolio companies (2) with products that can benefit from testing in Russian clinical trial centers and (3) are interested in commercializing innovative therapeutics in the Russian market. The Maxwell Biotech Venture Fund's primary goal is to invest in Russian-based companies that are developing innovative products and technologies for the domestic and global markets. Maxwell also works with and invests in Western companies when they can help them advance their products along the development path, bring innovative products to the Russian market and generate superior return on investment. Typical investments range from $1 million to $10 million per company, depending on the stage of the company and its products. Maxwell is open to syndication with other venture firms. They place priority on investments that are likely to lead to a financial exit within 5 years. | Finance |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
DLVR Therapeutics, Inc.
 DLVR Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops oncology therapeutics | Commercial Services |
Cage Pharma, Inc.
 Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical drugs | Health Technology |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University School of Medicine
 Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cancer | Health Technology |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Technology Services |
IDD, Inc.
 IDD, Inc. Packaged SoftwareTechnology Services Specializes in custom software solutions, web design, mobile applications, media services, graphic design, digital and print marketing | Technology Services |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Clearpath Development Co.
 Clearpath Development Co. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical companies with an alternative mechanism for accelerating product development | Health Technology |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
University of Texas Health Science Center At San Antonio
 University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Hummingbird Bioscience | Health Technology |
